Clinical Trial for Mesothelioma Patients: Antineoplaston Therapy Concurrent Therapy Criteria

Read the concurrent therapy criteria for a current clinical trial being conducted to study the effects of Antineoplaston therapy for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.

Prior Concurrent Therapy:
Biologic therapy:
• At least 4 weeks since prior immunotherapy and recovered
• No concurrent immunomodulatory agents
Chemotherapy:
• At least 4 weeks since prior chemotherapy (6 weeks for nitrosoureas) and recovered
Endocrine therapy:
• Concurrent corticosteroids allowed
Radiotherapy:
• At least 8 weeks since prior radiotherapy (or less if multiple tumors) and recovered
Surgery:
• Recovered from prior surgery
Other:
• Prior cytodifferentiating agents allowed
• No prior antineoplastons
• No other concurrent antineoplastic agents

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney